GM1 Prophylaxis for WBRT Related Cognitive Dysfunction

NCT04395339 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

51

Enrollment

OTHER

Sponsor class

Stopped Difficulty accruing subjects the study accrual was closed

Conditions

Brain Metastases
Radiotherapy Side Effect
Cognitive Impairment
Gangliosidosis, GM1
Breast Cancer

Interventions

DRUG: Monosialotetrahexosyl ganglioside (GM1)
DRUG: Control

Sponsor

Sun Yat-sen University